Circular RNA-ITCH Suppresses Lung Cancer Proliferation via Inhibiting the Wnt/β-Catenin Pathway

Table 1

Baseline demographic and clinical characteristics of study populations.

Characteristics	Population		cir-ITCH relative expression	value
		(%)
Age (years)
≤40	10	12.82	0.0607 ± 0.0169	0.0076
40–60	31	39.74	0.0466 ± 0.0307
≥60	37	47.44	0.0357 ± 0.0155
Sex
Male	45	57.7	0.0432 ± 0.0257	0.9704
Female	33	42.3	0.0434 ± 0.0225
Family history
Yes	23	29.49	0.0441 ± 0.0290	0.8437
No	55	70.51	0.0429 ± 0.0221
Smoking
Never	53	67.95	0.0487 ± 0.0283	0.1713
Ever	25	32.05	0.0407 ± 0.0230
Drinking
Never	33	42.3	0.0478 ± 0.2352	0.1568
Ever	45	57.7	0.0399 ± 0.0244
Tumor type
Adenocarcinoma	29	37.18	0.0443 ± 0.0267	0.9183
Large cell carcinoma	25	32.05	0.0436 ± 0.0250
Squamous cell carcinoma	24	30.77	0.0416 ± 0.0218
Stage
I	18	23.08	0.0605 ± 0.0273	0.0011
II	21	26.92	0.0444 ± 0.0260
III	22	28.21	0.0375 ± 0.0182
IV	17	21.79	0.0309 ± 0.0142

< 0.05 means statistically significant difference existed within subgroups.
Relative expression value was normalized to GAPDH expression level.